Characterization of tuberculosis drug resistance patterns in the early days of XDR-TB

Le résumé fourni par la source

Drug-resistant tuberculosis is considered one of the major threats to tuberculosis (TB) control, namely in the forms of Multidrug-Resistant TB (MDR-TB) and Extensively Drug Resistant TB (XDR-TB). The term XDR-TB was coined in 2005 to describe strains of MDR-TB that are also resistant to fluoroquinolones and second-line injectable drugs. In a 2006 CDC/WHO survey of 17690 isolates of M. tuberculosis, 20% were found to be MDR‐TB and 2% were XDR-TB. Other reports also showed a higher prevalence (53%) of XDR-TB isolates in Portugal. Given this context, we collected data from the Portuguese National Reference Centre for MDR-TB located at the last working Portuguese sanatorium. We conducted a retrospective descriptive study, analyzing the drug susceptibility test (DST) results from then recently admitted drug-resistant TB patients, from 1994 to 1998. All cultures and phenotypic DST were performed in the National Reference Laboratory. A total of 113 patients were included. There were 79 patients (69.9%) fulfilling criteria for MDR-TB and 35 patients (31,0%) for XDR-TB. In the MDR-TB group, 41 patients (36.3%) also presented resistance to ethambutol, 93 (82.3%) to streptomycin, and 19 (16.8%) to pyrazinamide. The resistance pattern for second-line drugs in this group was variable. With regard to the trends in resistance patterns over the study period, we observed a downward trend in the prevalence of resistance to all of the drugs from 1996 forward. Our data confirms the high prevalence of XDR-TB cases in Portugal. Although the exact reasons for this are unknown, we postulate that it may be related to the high percentage of African immigrants from the former Portuguese colonies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.